Read More Analyst Ratings Unveiling 25 Analyst Insights On Lyft By Benzinga Insights May 9, 12:00 PM Ratings for Lyft (NASDAQ:LYFT) were provided by 25 analysts in the past three months, showcasing a mix of… LYFT
Read More Biotech FDA General News OrthoPediatrics Corp. Receives “Breakthrough Device” Designation From FDA For eLLi Growing Rod System For Pediatric Patients With Scoliosis By Benzinga Newsdesk May 2, 5:12 PM OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received the "Breakthrough Device" Designation from the Food KIDS
Read More Analyst Ratings News Price Target Upgrades Morgan Stanley Upgrades GXO Logistics to Overweight, Raises Price Target to $60 By Benzinga Newsdesk January 9, 7:21 AM Morgan Stanley analyst Ravi Shanker upgrades GXO Logistics (NYSE:GXO) from Equal-Weight to Overweight and raises the price target from $45 to $60. GXO
Read More News Tech Top Stories Tesla Senior Exec Calls Some Indian Media Reports About Expansion Plans ‘Totally Made Up’ — But Doesn’t Say Which Ones By Anan Ashraf April 15, 2:53 AM Tesla employees are often surprised at the news they receive on the company's plans for India, Patel said. TSLA